Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine

被引:49
作者
Chen, XQ
Du, JZ
Wang, YXS
机构
[1] Zhejiang Univ, Dept Biol & Technol Sci, Div Neurobiol & Physiol, Coll Life Sci, Hangzhou 310027, Peoples R China
[2] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada
基金
中国国家自然科学基金;
关键词
adrenoceptor; central nucleus of the amygdala; corticotropin-releasing factor; hypoxia; norepinephrine; stress;
D O I
10.1016/j.regpep.2004.02.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Corticotropin-releasing factor (CRF) peptide release was activated by hypoxia in the rat hypothalamus. The mechanisms, however, of the hypoxia-induced CRF release remains unclear. In this study, we demonstrated that the norepinephrine (NE) and its receptors in the paraventricular nucleus (PVN) mediated the CRF release in a simulated altitude hypoxia. When rats were exposed to 5 or 7 km altitude of hypoxia for a short or long term: (1) NE levels in the PVN and the CeA, using the HPLC analysis, were intensity and time course dependently increased, but the increase in the PVN were potential than in the CeA. Restraint-induced NE increase was much higher in both the PVN and the CeA, compared with hypoxia-induced response. (2) Hypoxia and restraint significantly enhanced CRF release in the ME and the PVN but not in the CeA, through RIA assay, which result in stimulating corticosterone secretion. (3) Hypoxia-induced CRF release was reversed by an injection of prazosin (icv), an alpha-1 adrenoceptor antagonist, while administration of yohimbine (icv), an alpha-2 receptor antagonist, facilitated further CRF release. These data suggested that hypoxia induced NE activation centrally, via alpha-1 and -2 receptors, leading to improving hypothalamic CRF release, which in turn stimulated pituitary and adrenal cortex. Restraint presented much potential action on NE activation than hypoxia. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:221 / 228
页数:8
相关论文
共 39 条
[21]   ADRENALECTOMY AUGMENTS IN-VIVO RELEASE OF NOREPINEPHRINE IN THE PARAVENTRICULAR NUCLEUS DURING IMMOBILIZATION STRESS [J].
PACAK, K ;
KVETNANSKY, R ;
PALKOVITS, M ;
FUKUHARA, K ;
YADID, G ;
KOPIN, IJ ;
GOLDSTEIN, DS .
ENDOCRINOLOGY, 1993, 133 (03) :1404-1410
[22]   EFFECTS OF SINGLE OR REPEATED IMMOBILIZATION ON RELEASE OF NOREPINEPHRINE AND ITS METABOLITES IN THE CENTRAL NUCLEUS OF THE AMYGDALA IN CONSCIOUS RATS [J].
PACAK, K ;
PALKOVITS, M ;
KVETNANSKY, R ;
FUKUHARA, K ;
ARMANDO, I ;
KOPIN, IJ ;
GOLDSTEIN, DS .
NEUROENDOCRINOLOGY, 1993, 57 (04) :626-633
[23]   STRESS-INDUCED NOREPINEPHRINE RELEASE IN THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS AND PITUITARY-ADRENOCORTICAL AND SYMPATHOADRENAL ACTIVITY - IN-VIVO MICRODIALYSIS STUDIES [J].
PACAK, K ;
PALKOVITS, M ;
KOPIN, IJ ;
GOLDSTEIN, DS .
FRONTIERS IN NEUROENDOCRINOLOGY, 1995, 16 (02) :89-150
[24]   Effects of various stressors an in vivo norepinephrine release in the hypothalamic paraventricular nucleus and on the pituitary-adrenocortical axis [J].
Pacak, K ;
Palkovits, M ;
Kvetnansky, RA ;
Yadid, G ;
Kopin, IJ ;
Goldstein, DS .
STRESS: BASIC MECHANISMS AND CLINICAL IMPLICATIONS, 1995, 771 :115-130
[25]  
PALKOVITS M, 1983, BRAIN MICRODISSECTIO, P1
[26]  
PICH EM, 1995, J NEUROSCI, V15, P5439
[27]   CENTRAL MODULATION OF IMMUNOREACTIVE CORTICOTROPIN-RELEASING FACTOR SECRETION BY ARGININE VASOPRESSIN [J].
PLOTSKY, PM ;
BRUHN, TO ;
VALE, W .
ENDOCRINOLOGY, 1984, 115 (04) :1639-1641
[28]   Anatomical interactions between the central amygdaloid nucleus and the hypothalamic paraventricular nucleus of the rat: a dual tract-tracing analysis [J].
Prewitt, CMF ;
Herman, JP .
JOURNAL OF CHEMICAL NEUROANATOMY, 1998, 15 (03) :173-185
[29]   Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs [J].
Quirarte, GL ;
Galvez, R ;
Roozendaal, B ;
McGaugh, JL .
BRAIN RESEARCH, 1998, 808 (02) :134-140
[30]   Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment [J].
Stout, SC ;
Owens, MJ ;
Nemeroff, CB .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :1085-1092